Options Research

Compare current setups

Put up to five tickers on the same scale. The comparison separates directional pressure, participation, volatility, trend agreement and data quality.

Return to Options Radar

Maximum five tickers. Scores measure evidence alignment, not the probability of a gain.

Strongest evidence alignment ORMP 36/100

The highest composite alignment across pressure, participation, trend fit and volatility.

Widest priced move ORMP 13.5%

The largest near-term move currently implied by the retained chain.

Strongest participation ORMP 0/100

The most active setup relative to open interest and contract-level flow.

Cleanest evidence ORMP A · 97/100

The comparison member with the strongest underlying, chain, quote and volatility coverage.

Side-by-side evidence

One scale, comparable inputs

1 current setups
Ticker Read Conviction Pressure Participation Volatility Trend fit Expected move Put-call Volume/OI Evidence
ORMPOramed Pharmaceuticals Inc Mixed 36 12 0 80 88 13.5% - 0.00 A97/100
Mixed

ORMP

Oramed Pharmaceuticals Inc

36
Priced range 3.52–4.62
Pressure
12
Participation
0
Trend fit
88
Reference IV
0.56

Options imply 3.52 to 4.62. Max pain at 2.50 lies outside the priced range, so it is a weak near-term anchor.

Open ORMP research